Our results are consistent with the data published on Fusobacteria/colon cancer cells interaction showing that Fusobacteria can activate multiple pathways in cancer cells, including E-cadherin and NF-KB pathways [26,46]. This evidence concerns the gene NFKB1 and colonic neoplasm.